Effects of the tumor microenvironment on the efficacy of tumor immunotherapy. (Q36569004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

Effects of the tumor microenvironment on the efficacy of tumor immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

28 December 2019

Yvonne Paterson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Paul Neeson

series ordinal

1

1 reference

15 August 2017

Yvonne Paterson

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

Immunological Investigations

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

28 December 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

28 December 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

359-394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

Chemokines in lymphopoiesis and lymphoid organ development

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Cytokine modified tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

The IFN gamma receptor: a paradigm for cytokine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Angiomotin regulates endothelial cell-cell junctions and cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Tumors and inflammatory infiltrates: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Stat proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

A critical role for Stat3 signaling in immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Genetically engineered tumor cell vaccine in a head and neck cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Immunotherapy for gynaecological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

CD4 T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Immune Enhancement of Skin Carcinogenesis by CD4 T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

STATs and Gene Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

The molecular cell biology of interferon-gamma and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors im

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Glucocorticoids do not inhibit antitumor activity of activated CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

CCL27-CCR10 interactions regulate T cell-mediated skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4( )CD25( ) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Antigen-independent accumulation of activated effector/memory T lymphocytes into human and murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Chemokines and the tissue-specific migration of lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8( ) T-cell responses that home to the tumor site

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Stats: transcriptional control and biological impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Role of nitric oxide synthesis in macrophage antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Vaccine-stimulated, adoptively transferred CD8 T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Immune responses to Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Naturally-occurring CD4 CD25 immunoregulatory T cells: central players in the arena of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Alternative activation of STAT1 and STAT3 in response to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Naturally arising Foxp3-expressing CD25 CD4 regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Direct evidence on the immune-mediated spontaneous regression of human cancer: an incentive for pharmaceutical companies to develop a novel anti-cancer vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Chemoattractants and their receptors in homeostasis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

The role of chemokine receptors in primary, effector, and memory immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Derangement of immune responses by myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Genetic changes occurring in established tumors rapidly stimulate new antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Bystander elimination of antigen loss variants in established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25( ) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Immunobiology of lnterleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Plasmacytoid dendritic cells induce CD8 regulatory T cells in human ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Characterization of phosphopeptide motifs specific for the Src homology 2 domains of signal transducer and activator of transcription 1 (STAT1) and STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Adoptive T cell therapy using antigen-specific CD8 T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Complementary role of CD4 T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8 T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8 T cells: eradication of autologous mouse prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

T cell-mediated suppression of angiogenesis results in tumor protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Mechanism of action of rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Synergy between tumor immunotherapy and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08820130600755009

10.1080/08820130600755009

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16916758 AND SRC:MED&resulttype=core&format=json

28 December 2019

1 reference